Sanofi Bags Genzyme With Incentive-Laden $20B Offer
French pharmaceutical giant Sanofi-Aventis SA reached a $20.1 billion deal to buy Genzyme Corp. Wednesday, bumping its offer to $74 per share and tacking on incentives for Genzyme investors that could...To view the full article, register now.
Already a subscriber? Click here to view full article